EPSRC logo

Details of Grant 

EPSRC Reference: EP/K503332/1
Title: CENTRE FOR DOCTORAL TRAINING IN THE EPSRC CENTRE FOR INNOVATIVE MANUFACTURING IN EMERGENT MACROMOLECULAR THERAPIES
Principal Investigator: Dalby, Professor PA
Other Investigators:
Szita, Professor N
Researcher Co-Investigators:
Project Partners:
Department: Biochemical Engineering
Organisation: UCL
Scheme: CDT - NR1
Starts: 01 October 2012 Ends: 31 March 2019 Value (£): 2,410,819
EPSRC Research Topic Classifications:
Biochemical engineering
EPSRC Industrial Sector Classifications:
Manufacturing Healthcare
Pharmaceuticals and Biotechnology
Related Grants:
Panel History:
Panel DatePanel NameOutcome
28 Mar 2012 Manufacturing the Future-Centres for Doctoral Training Announced
Summary on Grant Application Form
The focus of the proposed EPSRC CDT will be on manufacturing research and training required in the most rapidly

developing parts of the UK bio-centred pharmaceutical and healthcare biotechnology sector, that have major implications

for future medicine. The bioprocess industry manufactures novel macromolecular drugs, proteins, to address a broad range

of chronic and debilitating human diseases. The UK holds a leading position by virtue of its science base and has unique university capabilities underpinning the sector. Whilst revenues are large, ~£110bn in 2009 on a worldwide basis, there are

huge pressures on the industry for change if demands for cost reduction and waste minimisation are to be met, and

populations are to benefit from the potent drugs becoming available. A sea change in manufacturing will be needed over

the next decade if the potential of modern drugs are to make their way through to widespread distribution. Moreover this is

a widely accepted skills shortage of individuals with the manufacturing research training needed for the sector.

Alignment to the EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies will deliver increased

national capability through training of the next generation of highly skilled and talented bioprocess manufacturing

researchers. Our aim is to train bioprocess engineering leaders of the future who will underpin translation of new scientific

advances into safely produced, more selective, therapies for currently intractable conditions at affordable costs. To achieve

this we will embed CDT PhDs within the vibrant research community of the top UK Institutions and that of the EPSRC

Centre for Innovative Manufacturing in Emergent Macromolecular Therapies, to ensure that they benefit in terms of impact

and knowledge transfer from the links to research led companies. The gearing in of these collaborations will enable the

CDT to explore new and emerging ideas in a training environment that draw on research excellence and to create strong

synergy between the Centre research programmes.
Key Findings
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Potential use in non-academic contexts
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Impacts
Description This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Summary
Date Materialised
Sectors submitted by the Researcher
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Project URL:  
Further Information:  
Organisation Website: